The city of Chicago, Illinois, currently has 39 active clinical trials seeking participants for Diabetes research studies.
A Hybrid Effectiveness-implementation Trial to Reduce Diabetes Distress in Teenagers
Recruiting
The investigators will assess both effectiveness (primary) and implementation (secondary) outcomes for a distress-reducing intervention, Supporting Teen Problem Solving (STePS). STePS has already undergone an efficacy trial. The current study allows for evaluating the outcomes of STePS by delivering it in real-world settings, using real-world providers. The investigators will train these behavioral health providers who are already embedded in diabetes clinics to use the STePS intervention. The i... Read More
Gender:
ALL
Ages:
Between 14 years and 18 years
Trial Updated:
11/25/2024
Locations: Ann and Robert H Lurie Childrens Hospital of Chicago, Chicago, Illinois
Conditions: Type 1 Diabetes Mellitus
A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Recruiting
The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously into biopsied and non-biopsied contralateral kidneys in participants with T2DM and CKD.
Gender:
ALL
Ages:
Between 30 years and 80 years
Trial Updated:
11/22/2024
Locations: Insight Hospital & Medical Center Chicago, Chicago, Illinois +1 locations
Conditions: Type 2 Diabetes Mellitus, Chronic Kidney Diseases
Islet Transplantation in Type 1 Diabetic Kidney Allograft
Recruiting
The purpose of this study is to learn about the safety of islet transplantation when performed after kidney transplantation, which may provide more normal control of blood sugar without the need for insulin shots. Islets are special clusters of cells within the pancreas that produce insulin. These cells will be obtained from cadaver (non-living) donors and given to subjects by vein.
Gender:
ALL
Ages:
Between 18 years and 68 years
Trial Updated:
11/22/2024
Locations: The University of Chicago, Chicago, Illinois
Conditions: Diabetes Mellitus, Type 1
Black Girls Move Physical Activity and Improving Dietary Intake Among Black Adolescent Daughters
Recruiting
Black Girls Move is a school-linked daughter/mother physical activity and dietary behavior program, with 9th and 10th grade students. This program is designed to prevent obesity in Black adolescent females and thus aligns with the NIH mission to enhance health, lengthen life, and reduce illness and disability. This project is relevant to public health because it holds the potential to reduce population health disparities impacted by structural racism.
Gender:
FEMALE
Ages:
Between 12 years and 18 years
Trial Updated:
11/19/2024
Locations: Rush University Medical Center, Chicago, Illinois
Conditions: Adolescent Obesity, Diabetes Mellitus
Promoting Preconception Care and Diabetes Self-Management Among Reproductive-Aged Women With Diabetes
Recruiting
This study is being done to investigate strategies that may improve patient's knowledge of type 2 diabetes during reproductive age and improve knowledge and engagement in self-care activities.
Gender:
FEMALE
Ages:
Between 18 years and 44 years
Trial Updated:
10/23/2024
Locations: Northwestern University, Chicago, Illinois
Conditions: Diabetes Mellitus, Type 2, Electronic Health Record, Primary Health Care, Reproductive Behavior
Empowering Veterans to Actively Communicate and Engage in Shared Decision Making in Medical Visits, A Randomized Controlled Trial
Recruiting
Type 2 diabetes is a significant condition in VA affecting 20% of VA patients. Adherence to medication regimens and lifestyle factors is important to achieve care goals for these patients. Patients who use active participatory communication behaviors with their providers have better adherence to treatment and better biomedical outcomes, yet many patients are not prepared to engage in active communication with their providers. Existing coaching interventions have not been adopted in practice beca... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/08/2024
Locations: Lakeside VA Clinic, Chicago, Illinois +1 locations
Conditions: Diabetes Mellitus (Type 2)
Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D)
Recruiting
AT-1501 is a monoclonal antibody. Antibodies are Y-shaped proteins that are produced naturally by the subject's immune system to attack and fight foreign substances that cause illness. Monoclonal antibodies are man-made proteins manufactured to serve as substitute antibodies to fight diseases. Monoclonal antibodies can restore, enhance, or mimic (copy) the immune system's attack process; they can also tone down the immune system. AT-1501 is thought to work by dampening down the immune system so... Read More
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
09/16/2024
Locations: University of Chicago, Chicago, Illinois
Conditions: Diabetes Mellitus
Supporting Transitions to Primary Care Among Under-resourced, Postpartum Women (STEP-UP)
Recruiting
STEP-UP will promote linkage to primary care and ongoing chronic disease evaluation for postpartum women with prior gestational diabetes mellitus (GDM) and/or hypertensive disorders of pregnancy (HDP).
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
09/04/2024
Locations: Cook County Health, Chicago, Illinois +1 locations
Conditions: Hypertension in Pregnancy, Gestational Diabetes Mellitus, Dysglycemia
Multivariable Artificial Pancreas: Detecting and Mitigating Unannounced Physical Activity and Acute Psychological Stress
Recruiting
The objective of this proposal is to demonstrate a viable, functionally integrated multivariable artificial pancreas (mvAP) that will address meal, physical activity (PA) and acute psychological stress (APS) challenges without any manual inputs to better regulate glucose levels of people with diabetes. Acute psychological stress and many other forms of PA besides planned exercise can affect blood glucose levels and cause challenges to maintaining euglycemia for people with type 1 diabetes mellit... Read More
Gender:
ALL
Ages:
Between 20 years and 60 years
Trial Updated:
08/26/2024
Locations: University of Illinois Chicago, Chicago, Illinois
Conditions: Type 1 Diabetes
MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors
Recruiting
Inflammation and stressors can interfere with the function of the lining of blood vessels and insulin activity, therefore, investigators are aiming to see how the Grape seed Extract (GSE) called MegaNatural BP can help with limiting the effects of these factors. This research will study the effects of taking 150mg of MegaNatural BP GSE per day on blood pressure levels along with influences on heart health through assessing the function of the blood vessel lining and levels of inflammation.
Gender:
ALL
Ages:
Between 40 years and 60 years
Trial Updated:
08/21/2024
Locations: Clinical Nutrition Research Center, Chicago, Illinois
Conditions: Hypertension, Pre Diabetes
Virtual Diabetes Group Visits Across Health Systems
Recruiting
The purpose of this project is to evaluate the effectiveness of a virtual diabetes group visits on patients with type 2 diabetes mellitus (T2DM).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/18/2024
Locations: Access Community Health Network, Chicago, Illinois
Conditions: T2DM (Type 2 Diabetes Mellitus), Hypertension, Heart Disease Chronic, Stroke, Hyperlipidemias, Peripheral Vascular Diseases, Obesity
Mechanisms of Prediabetic States in Sleep Apnea
Recruiting
The purpose of this study is to better understand how sleep apnea contributes to the development of diabetes.
Gender:
All
Ages:
Between 20 years and 65 years
Trial Updated:
05/07/2024
Locations: University of Chicago, Chicago, Illinois
Conditions: Sleep Apnea, Pre-diabetes